Dynamin 2 and human diseases - PubMed (original) (raw)

Review

Dynamin 2 and human diseases

Anne-Cécile Durieux et al. J Mol Med (Berl). 2010 Apr.

Abstract

Dynamin 2 (DNM2) mutations cause autosomal dominant centronuclear myopathy, a rare form of congenital myopathy, and intermediate and axonal forms of Charcot-Marie-Tooth disease, a peripheral neuropathy. DNM2 is a large GTPase mainly involved in membrane trafficking through its function in the formation and release of nascent vesicles from biological membranes. DNM2 participates in clathrin-dependent and clathrin-independent endocytosis and intracellular membrane trafficking (from endosomes and Golgi apparatus). Recent studies have also implicated DNM2 in exocytosis. DNM2 belongs to the machinery responsible for the formation of vesicles and regulates the cytoskeleton providing intracellular vesicle transport. In addition, DNM2 tightly interacts with and is involved in the regulation of actin and microtubule networks, independent from membrane trafficking processes. We summarize here the molecular, biochemical, and functional data on DNM2 and discuss the possible pathophysiological mechanisms via which DNM2 mutations can lead to two distinct neuromuscular disorders.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Cell Biol. 2001 Apr 16;153(2):351-66 - PubMed
    1. J Biol Chem. 2001 Dec 21;276(51):48458-65 - PubMed
    1. J Neurol. 2008 Jul;255(7):986-92 - PubMed
    1. Nat Cell Biol. 2004 Apr;6(4):335-42 - PubMed
    1. Neurology. 2007 Jul 17;69(3):291-5 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources